Almeida, M. S., & Quintanilha, A. (2017). Of responsible research?Exploring the science-society dialogue in undergraduate training within the life sciences. Biochemistry and Molecular Biology Education, 45(1), 46 - 52.

Gaskell, G., Bard, I., Allansdottir, A., Da Cunha, R. V., et al. (2017). Public views on gene editing and its uses. Nature Biotechnology, 35(11), 1022 - 1023.

Do Sameiro-Faria, M., Ribeiro, S., Rocha-Pereira, P., Fernandes, J., et al. (2013). Body mass index and resistance to recombinant human erythropoietin therapy in maintenance hemodialysis patients. Renal Failure, 35(10), 1392 - 1398.

Kohlova, M., Ribeiro, S., Do Sameiro-Faria, M., Rocha-Pereira, P., et al. (2013). Circulating cell-free DNA levels in hemodialysis patients and its association with inflammation, iron metabolism, and rhEPO doses. Hemodialysis International, 17(4), 664 - 667.

Coimbra, S., Oliveira, H., Reis, F., Belo, L., et al. (2013). Letter to the editor: A potential mechanism for the pathogenesis of psoriasis vulgaris. International Journal of Dermatology, 52(11), 1429 - 1432.

Nascimento, H., Costa, E., Rocha-Pereira, P., Rego, C., et al. (2012). Cardiovascular risk factors in Portuguese obese children and adolescents: Impact of small reductions in body mass index imposed by lifestyle modifications. Open Biochemistry Journal, 6, 43 - 50.

Coimbra, S., Oliveira, H., Reis, F., Belo, L., et al. (2012). Erythroid disturbances before and after treatment of Portuguese psoriasis vulgaris patients: A cross-sectional and longitudinal study. American Journal of Clinical Dermatology, 13(1), 37 - 47.

Catarino, C., Santos-Silva, A., Belo, L., Rocha-Pereira, P., et al. (2012). Inflammatory disturbances in preeclampsia: Relationship between maternal and umbilical cord blood. Journal of Pregnancy, 2012.

Coimbra, S., Oliveira, H., Reis, F., Belo, L., et al. (2012). Letter to the Editor: A potential mechanism for the pathogenesis of psoriasis vulgaris. International Journal of Dermatology.

Ribeiro, S., Do Sameiro Faria, M., Mascarenhas-Melo, F., Freitas, I., et al. (2012). Main determinants of PON1 activity in hemodialysis patients. American Journal of Nephrology, 36(4), 317 - 323.

Ribeiro, S., Faria, M. D. S., Silva, G., Nascimento, H., et al. (2012). Oxidized low-density lipoprotein and lipoprotein(a) levels in chronic kidney disease patients under hemodialysis: Influence of adiponectin and of a polymorphism in the apolipoprotein(a) gene. Hemodialysis International, 16(4), 481 - 490.

Rocha, S., Costa, E., Rocha-Pereira, P., Ferreira, F., et al. (2011). Complementary markers for the clinical severity classification of hereditary spherocytosis in unsplenectomized patients. Blood Cells, Molecules, and Diseases, 46(2), 166 - 170.

Rocha, S., Costa, E., Rocha-Pereira, P., Ferreira, F., et al. (2011). Erythropoiesis versus inflammation in Hereditary Spherocytosis clinical outcome. Clinical Biochemistry, 44(13), 1137 - 1143.

Coimbra, S., Oliveira, H., Reis, F., Belo, L., et al. (2010). Circulating adipokine levels in Portuguese patients with psoriasis vulgaris according to body mass index, severity and therapy. Journal of the European Academy of Dermatology and Venereology, 24(12), 1386 - 1394.

Coimbra, S., Oliveira, H., Reis, F., Belo, L., et al. (2010). C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy. Journal of the European Academy of Dermatology and Venereology, 24(7), 789 - 796.

Rocha, S., Costa, E., Rocha-Pereira, P., Ferreira, F., et al. (2010). Erythrocyte membrane protein destabilization versus clinical outcome in 160 Portuguese Hereditary Spherocytosis patients. British Journal of Haematology, 149(5), 785 - 794.

Rocha, S., Costa, E., Ferreira, F., Cleto, E., et al. (2010). Hereditary spherocytosis and the (TA)nTAA polymorphism of UGT1A1 gene promoter region-A comparison of the bilirubin plasmatic levels in the different clinical forms. Blood Cells, Molecules, and Diseases, 44(2), 117 - 119.

Nascimento, H., Belo, L., Fernandes, J., Rocha, S., et al. (2010). In vitro studies with 'acatalasemic-like' erythrocytes and hydrogen peroxide: Attention to the formation of lysis resistant erythrocytes. International Journal of Laboratory Hematology, 32(1 PART.2), 127 - 131.

Coimbra, S., Oliveira, H., Reis, F., Belo, L., et al. (2010). Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-? levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy. British Journal of Dermatology, 163(6), 1282 - 1290.

Pereira, R., Costa, E., Gonçalves, M., Miranda, V., et al. (2010). Neutrophil and monocyte activation in chronic kidney disease patients under hemodialysis and its relationship with resistance to recombinant human erythropoietin and to the hemodialysis procedure. Hemodialysis International, 14(3), 295 - 301.

Coimbra, S., Oliveira, H., Reis, F., Belo, L., et al. (2009). Circulating levels of adiponectin, oxidized LDL and C-reactive protein in Portuguese patients with psoriasis vulgaris, according to body mass index, severity and duration of the disease. Journal of Dermatological Science, 55(3), 202 - 204.

Costa, E., Rocha, S., Rocha-Pereira, P., Reis, F., et al. (2009). Effect of hemodialysis procedure in prohepcidin serum levels in regular hemodialysis patients. Clinical Nephrology, 71(2), 233 - 235.

Catarino, C., Rebelo, I., Belo, L., Rocha-Pereira, P., et al. (2009). Erythrocyte changes in preeclampsia: Relationship between maternal and cord blood erythrocyte damage. Journal of Perinatal Medicine, 37(1), 19 - 27.

Catarino, C., Rebelo, I., Belo, L., Rocha, S., et al. (2009). Fetal and maternal angiogenic/anti-angiogenic factors in normal and preeclamptic pregnancy. Growth Factors, 27(6), 345 - 351.

Costa, E., Swinkels, D. W., Laarakkers, C. M., Rocha-Pereira, P., et al. (2009). Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in haemodialysis patients. Acta Haematologica, 122(4), 226 - 229.

Rocha, S., Costa, E., Coimbra, S., Nascimento, H., et al. (2009). Linkage of cytosolic peroxiredoxin 2 to erythrocyte membrane imposed by hydrogen peroxide-induced oxidative stress. Blood Cells, Molecules, and Diseases, 43(1), 68 - 73.

Nascimento, H., Silva, L. L., Lourenço, P., Vieira, E., et al. (2009). Lipoprotein(a) levels in obese portuguese children and adolescents: Contribution of the pentanucleotide repeat (TTTTA)n polymorphism in the apolipoprotein(a) gene. Archives of Pediatrics and Adolescent Medicine, 163(4), 393 - 394.

Costa, E., Rocha, S., Rocha-Pereira, P., Castro, E., et al. (2008). Altered erythrocyte membrane protein composition in chronic kidney disease stage 5 patients under haemodialysis and recombinant human erythropoietin therapy. Blood Purification, 26(3), 267 - 273.

Costa, E., Rocha, S., Rocha-Pereira, P., Castro, E., et al. (2008). Changes in red blood cells membrane protein composition during hemodialysis procedure. Renal Failure, 30(10), 971 - 975.

Costa, E., Rocha, S., Rocha-Pereira, P., Castro, E., et al. (2008). Cross-talk between inflammation, coagulation/fibrinolysis and vascular access in hemodialysis patients. Journal of Vascular Access, 9(4), 248 - 253.

Costa, E., Rocha, S., Rocha-Pereira, P., Reis, F., et al. (2008). DMT1 (NRAMP2/DCT1) Genetic Variability and Resistance to Recombinant Human Erythropoietin Therapy in Chronic Kidney Disease Patients under Haemodialysis. Acta Haematologica, 120(1), 11 - 13.

Catarino, C., Rebelo, I., Belo, L., Rocha-Pereira, P., et al. (2008). Fetal lipoprotein changes in pre-eclampsia. Acta Obstetricia et Gynecologica Scandinavica, 87(6), 628 - 634.

Costa, E., Lima, M., Rocha, S., Rocha-Pereira, P., et al. (2008). IL-7 serum levels and lymphopenia in hemodialysis patients, non-responders to recombinant human erythropoietin therapy. Blood Cells, Molecules, and Diseases, 41(1), 134 - 135.

Costa, E., Lima, M., Alves, J. M., Rocha, S., et al. (2008). Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy. Journal of Clinical Immunology, 28(3), 268 - 275.

Costa, E., Rocha, S., Rocha-Pereira, P., Nascimento, H., et al. (2008). Neutrophil activation and resistance to recombinant human erythropoietin therapy in hemodialysis patients. American Journal of Nephrology, 28(6), 935 - 940.

Rocha, S., Vitorino, R. M. P., Lemos-Amado, F. M., Castro, E. B., et al. (2008). Presence of cytosolic peroxiredoxin 2 in the erythrocyte membrane of patients with hereditary spherocytosis. Blood Cells, Molecules, and Diseases, 41(1), 5 - 9.

Catarino, C., Rebelo, I., Belo, L., Rocha, S., et al. (2008). Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies. Thrombosis Research, 123(2), 219 - 224.

Costa, E., Pereira, B. J. G., Rocha-Pereira, P., Rocha, S., et al. (2008). Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients. American Journal of Nephrology, 28(4), 677 - 683.

Belo, L., Santos-Silva, A., Quintanilha, A., & Rebelo, I. (2008). Similarities between pre-eclampsia and atherosclerosis: A protective effect of physical exercise?. Current Medicinal Chemistry, 15(22), 2223 - 2229.

Costa, V., Quintanilha, A., & Moradas-Ferreira, P. (2007). Protein oxidation, repair mechanisms and proteolysis in Saccharomyces cerevisiae. IUBMB Life, 59(4-5), 293 - 298.

Belo, L., Santos-Silva, A., Quintanilha, A., & Rebelo, I. (2006). Pre-eclampsia versus cardiovascular disease versus CRP. Current Hypertension Reviews, 2(4), 317 - 323.

Rocha, S., Costa, E., Catarino, C., Belo, L., et al. (2005). Erythropoietin levels in the different clinical forms of hereditary spherocytosis. British Journal of Haematology, 131(4), 534 - 542.

Belo, L., Santos-Silva, A., Rocha, S., Caslake, M., et al. (2005). Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy. European Journal of Obstetrics Gynecology and Reproductive Biology, 123(1), 46 - 51.

Belo, L., Santos-Silva, A., Lowe, G., Rumley, A., et al. (2005). High-density lipoprotein particles may regulate hemostasis in human pregnancy. Fertility and Sterility, 84(4), 1021 - 1022.

Belo, L., Santos-Silva, A., Caslake, M., Pereira-Leite, L., et al. (2005). Oxidized-LDL levels in normal and pre-eclamptic pregnancies: Contribution of LDL particle size [2]. Atherosclerosis, 183(1), 185 - 186.

Rocha, S., Rebelo, I., Costa, E., Catarino, C., et al. (2005). Protein deficiency balance as a predictor of clinical outcome in hereditary spherocytosis. European Journal of Haematology, 74(5), 374 - 380.

Belo, L., Gaffney, D., Caslake, M., Santos-Silva, A., et al. (2004). Apolipoprotein e and cholesteryl ester transfer protein polymorphisms in normal and preeclamptic pregnancies. European Journal of Obstetrics Gynecology and Reproductive Biology, 112(1), 9 - 15.

Branca, R., Costa, E., Rocha, S., Coelho, H., et al. (2004). Coexistence of congenital red cell pyruvate kinase and band 3 deficiency. Clinical and Laboratory Haematology, 26(4), 297 - 300.

Rocha-Pereira, P., Santos-Silva, A., Rebelo, I., Figneiredo, A., et al. (2004). Erythrocyte damage in mild and severe psoriasis. British Journal of Dermatology, 150(2), 232 - 244.

Rocha-Pereira, P., Santos-Silva, A., Rebelo, I., Figueiredo, A., et al. (2004). The inflammatory response in mild and in severe psoriasis. British Journal of Dermatology, 150(5), 917 - 928.

Belo, L., Caslake, M., Santos-Silva, A., Castro, E. M. B., et al. (2004). LDL size, total antioxidant status and oxidised LDL in normal human pregnancy: A longitudinal study. Atherosclerosis, 177(2), 391 - 399.

Quintanilha, A. (2004). A word from the public research. Chimica Oggi, 22(6), 61.